A comparison of the effects of olopatadine and ketotifen on model membranes

H Brockman, G Graff, J Spellman… - Acta Ophthalmologica …, 2000 - Wiley Online Library
Olopatadine is a human conjunctival mast cell stabilizer with anti‐histaminic activity.
Ketotifen is an older molecule that possesses antihistaminic activity and is reported to have …

Interactions of olopatadine and selected antihistamines with model and natural membranes

HL Brockman, MM Momsen, JR Knudtson… - Ocular Immunology …, 2003 - Taylor & Francis
Objective: Olopatadine, an effective topical ocular human conjunctival mast cell stabilizer/
antihistaminic antiallergic drug, was evaluated and compared to selected classical …

In Vitro Inhibition of Human Conjunctival Mast-Cell Degranulation by Ketotifen

C Schoch - Journal of ocular pharmacology and therapeutics, 2003 - liebertpub.com
Ketotifen relieves the symptoms of allergic conjunctivitis through multiple mechanisms of
action. One such mechanism may involve stabilization of conjunctival mast cells. Because of …

Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research

LJ Rosenwasser, T O'Brien, J Weyne - Current medical research …, 2005 - Taylor & Francis
Background: Histamine receptor activation and degranulation of mast cells are the
mechanisms by which the ocular itching, hyperemia, chemosis, eyelid swelling, and tearing …

Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge …

A Leonardi, MB Abelson - Clinical therapeutics, 2003 - Elsevier
Objective: The purpose of this study was to assess the effects of olopatadine on the release
of mast cell-derived mediators after conjunctival allergen challenge (CAC) in humans …

The In Vitro and In Vivo Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic Agent

JM Yanni, DJ Stephens, ST Miller… - Journal of ocular …, 1996 - liebertpub.com
ABSTRACT Olopatadine (AL-4943A; KW-4679)[(z)-11-[3-(dimethylamino) propylidene]-6, 11-
dihydrodibenz [b, e] oxepine-2 acetic acid hydrochloride] is an anti-allergic agent which …

Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells

JM Yanni, ST Miller, DA Gamache, JM Spellman… - Annals of Allergy …, 1997 - Elsevier
BACKGROUND: The concept of mast cell heterogeneity is well established. Recent data
indicate that human conjunctival tissue mast cells and human connective tissue mast cells …

Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.

NA Sharif, SX Xu, ST Miller, DA Gamache… - Journal of Pharmacology …, 1996 - ASPET
Olopatadine (AL-4943A; KW-4679)[(Z)-11-[3-(dimethylamino) propylidene]-6, 11-
dihydrodibenz [b, e] oxepine-2-acetic acid hydrochloride] is an antiallergic/antihistaminic …

A review of the use of olopatadine in allergic conjunctivitis

JI McGill - International ophthalmology, 2004 - Springer
Ocular allergies are very common and range in intensity from mild, self-resolving, acute
conditions to serious, chronic disease that can severely affect vision. The vast majority of …

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell

A Leonardi, L Quintieri - Expert Opinion on Pharmacotherapy, 2010 - Taylor & Francis
Importance of the field: Ocular allergic diseases are characterized by specific activation of
conjunctival mast cells with subsequent release of preformed and newly formed mediators …